[1]
Demachi, T. et al. 2026. Multidisciplinary Team Management of Lenvatinib Therapy in Differentiated Thyroid Cancer: Real-World Long-Term Treatment Outcomes. Balkan ORL-HNS. 3, 1 (Jul. 2026), 1–10. DOI:https://doi.org/10.5152/bohns.2026.25133.